Recombinant Human Interleukin-35/IL-35 (C-Fc)

Introducing the Recombinant Human Interleukin-35/IL-35 (C-Fc), a highly advanced and innovative product designed to enhance the immune system and promote overall health and well-being. This product is a fusion protein consisting of the C-terminal domain of the p35 subunit of IL-12 and the entire EBI3 subunit of IL-27, which is expressed as a single polypeptide chain with a C-terminal Fc tag.

The Recombinant Human Interleukin-35/IL-35 (C-Fc) is produced using state-of-the-art recombinant DNA technology, ensuring the highest level of purity and quality. This product is designed to stimulate the immune system by promoting the differentiation of regulatory T cells and suppressing the activity of effector T cells.

The Recombinant Human Interleukin-35/IL-35 (C-Fc) is a highly effective product that has been extensively tested and proven to be safe for use. It is suitable for a wide range of applications, including research, diagnostic, and therapeutic purposes.

In summary, the Recombinant Human Interleukin-35/IL-35 (C-Fc) is a cutting-edge product that offers a range of benefits for the immune system and overall health. Its advanced design and high-quality production make it a reliable and effective choice for a variety of applications.